 | • レポートコード：MRC-IM30337 • 出版社/出版日：IMARC / 2022年11月 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥359,856 (USD2,499) | ▷ お問い合わせ |
| Enterprisewide | ￥647,856 (USD4,499) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| グローバル調査会社のIMARC社は、2021年132.8億ドルであった世界の出血性疾患治療市場規模が2027年には192.2億ドルに達し、予測期間中、年平均6.12％成長すると予測しています。本調査レポートでは、出血性疾患治療の世界市場を調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、種類別（血友病A、血友病B、フォン・ヴィレブランド病、その他）分析、医薬品クラス別（血漿由来凝固因子濃縮物、組換え凝固因子濃縮物、デスモプレシン、抗線維素溶解薬、その他）分析、流通チャネル別（病院薬局、小売薬局、オンライン）分析、エンドユーザー別（病院、診療所、学術・研究機関）分析、地域別（北米、アジア、欧州、中南米、中東・アフリカ）分析、SWOT分析（強み・弱み・機会・脅威）、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目を掲載しています。また、こちらの調査レポートに掲載されている企業情報には、AbbVie Inc, Alnylam Pharmaceuticals Inc., Bayer AG, CSL Behring (CSL Limited), Grifols S.A., Johnson & Johnson, Novo Nordisk A/S, Octapharma AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limitedなどが含まれています。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション ・世界の出血性疾患治療市場規模：種類別 - 血友病Aの市場規模 - 血友病Bの市場規模 - フォン・ヴィレブランド病の市場規模 - その他出血性疾患治療の市場規模 ・世界の出血性疾患治療市場規模：医薬品クラス別 - 血漿由来凝固因子濃縮物における市場規模 - 組換え凝固因子濃縮物における市場規模 - デスモプレシンにおける市場規模 - 抗線維素溶解薬における市場規模 - その他出血性疾患治療における市場規模 ・世界の出血性疾患治療市場規模：流通チャネル別 - 病院薬局チャネルの市場規模 - 小売薬局チャネルの市場規模 - オンラインチャネルの市場規模 ・世界の出血性疾患治療市場規模：エンドユーザー別 - 病院における市場規模 - 診療所における市場規模 - 学術・研究機関における市場規模 ・世界の出血性疾患治療市場規模：地域別 - 北米の出血性疾患治療市場規模 - アジアの出血性疾患治療市場規模 - 欧州の出血性疾患治療市場規模 - 中南米の出血性疾患治療市場規模 - 中東・アフリカの出血性疾患治療市場規模 ・SWOT分析（強み・弱み・機会・脅威） ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競争状況 |
The global bleeding disorders treatment market size reached US$ 13.28 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 19.22 Billion by 2027, exhibiting a growth rate (CAGR) of 6.12% during 2022-2027.
Bleeding disorders involve hemophilia A and B, Von Willebrand disease, idiopathic thrombocytopenic purpura (ITP), and deficiencies of vitamin K and factors II, V, VII, X, and XII. They are a class of conditions that disrupt the blood clotting process in an individual. They can also lead to heavy and prolonged bleeding after an injury. They have symptoms, including heavy menstrual bleeding, easy bruising, frequent nosebleeds, excessive bleeding from minor cuts, and joint bleeding. They are diagnosed through blood tests of complete blood count (CBC), platelet aggregation, and bleeding time. Their treatment comprises medications, including adrenochrome monosemicarbazone, retinal hemorrhage, epistaxis, aminocaproic acid, aprotinin, and iron supplements. These medications can aid in minimizing specific symptoms and prolonging the life of patients. Bleeding disorders treatment also includes blood transfusion, replacement therapy, and injections of a clotting factor and plasma.
Bleeding Disorders Treatment Market Trends:
The increasing prevalence of bleeding disorders among the masses and the rising geriatric population, which is more susceptible to these medical conditions, are among the key factors driving the market around the world. Moreover, the growing adoption of health insurance policies that provide financial assistance for bleeding disorders treatment and reduce healthcare expenses is influencing the market positively. In addition, governing agencies of numerous countries are generating awareness about blood and plasma donation. They are also undertaking initiatives to promote blood donation camps. Apart from this, the increasing awareness about the availability of effective treatment alternatives is creating a positive outlook for the market. Furthermore, research and development (R&D) activities and considerable improvements in the healthcare infrastructure and diagnostic technologies are expected to provide a favorable outlook to the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global bleeding disorders treatment market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, drug class, distribution channel and end user.
Breakup by Type:
Hemophilia A
Hemophilia B
Von Willebrand Disease
Others
Breakup by Drug Class:
Plasma-derived Coagulation Factor Concentrates
Factor VIII
Factor IX
Factor for Von Willebrand Disease
Activated Prothrombin Complex Concentrate
Recombinant Coagulation Factor Concentrates
Factor VIII
Factor for Von Willebrand Disease
Factor IX
Desmopressin
Antifibrinolytics
Fibrin Sealants
Others
Breakup by Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Stores
Breakup by End User:
Hospitals
Clinics
Academic and Research Institutes
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc, Alnylam Pharmaceuticals Inc., Bayer AG, CSL Behring (CSL Limited), Grifols S.A., Johnson & Johnson, Novo Nordisk A/S, Octapharma AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited and Wellona Pharma.
Key Questions Answered in This Report:
How has the global bleeding disorders treatment market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global bleeding disorders treatment market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the drug class?
What is the breakup of the market based on the distribution channel?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global bleeding disorders treatment market and who are the key players?
What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Bleeding Disorders Treatment Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Hemophilia A
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Hemophilia B
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Von Willebrand Disease
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Drug Class
7.1 Plasma-derived Coagulation Factor Concentrates
7.1.1 Market Trends
7.1.2 Key Segments
7.1.2.1 Factor VIII
7.1.2.2 Factor IX
7.1.2.3 Factor for Von Willebrand Disease
7.1.2.4 Activated Prothrombin Complex Concentrate
7.1.3 Market Forecast
7.2 Recombinant Coagulation Factor Concentrates
7.2.1 Market Trends
7.2.2 Key Segments
7.2.2.1 Factor VIII
7.2.2.2 Factor for Von Willebrand Disease
7.2.2.3 Factor IX
7.2.3 Market Forecast
7.3 Desmopressin
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Antifibrinolytics
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Fibrin Sealants
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by Distribution Channel
8.1 Hospital Pharmacies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Retail Pharmacies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Online Stores
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by End User
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Clinics
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Academic and Research Institutes
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 AbbVie Inc
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Alnylam Pharmaceuticals Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Bayer AG
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 CSL Behring (CSL Limited)
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 Grifols S.A.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Johnson & Johnson
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Novo Nordisk A/S
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Octapharma AG
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 SWOT Analysis
15.3.9 Pfizer Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Sanofi S.A.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Takeda Pharmaceutical Company Limited
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 Wellona Pharma
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
Figure 2: Global: Bleeding Disorders Treatment Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Bleeding Disorders Treatment Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Bleeding Disorders Treatment Market: Breakup by Type (in %), 2021
Figure 5: Global: Bleeding Disorders Treatment Market: Breakup by Drug Class (in %), 2021
Figure 6: Global: Bleeding Disorders Treatment Market: Breakup by Distribution Channel (in %), 2021
Figure 7: Global: Bleeding Disorders Treatment Market: Breakup by End User (in %), 2021
Figure 8: Global: Bleeding Disorders Treatment Market: Breakup by Region (in %), 2021
Figure 9: Global: Bleeding Disorders Treatment (Hemophilia A) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Bleeding Disorders Treatment (Hemophilia A) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Bleeding Disorders Treatment (Hemophilia B) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Bleeding Disorders Treatment (Hemophilia B) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Bleeding Disorders Treatment (Von Willebrand Disease) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Bleeding Disorders Treatment (Von Willebrand Disease) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Bleeding Disorders Treatment (Other Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Bleeding Disorders Treatment (Other Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Bleeding Disorders Treatment (Plasma-derived Coagulation Factor Concentrates) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Bleeding Disorders Treatment (Plasma-derived Coagulation Factor Concentrates) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Bleeding Disorders Treatment (Recombinant Coagulation Factor Concentrates) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Bleeding Disorders Treatment (Recombinant Coagulation Factor Concentrates) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Bleeding Disorders Treatment (Desmopressin) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Bleeding Disorders Treatment (Desmopressin) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Bleeding Disorders Treatment (Antifibrinolytics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Bleeding Disorders Treatment (Antifibrinolytics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Bleeding Disorders Treatment (Fibrin Sealants) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Bleeding Disorders Treatment (Fibrin Sealants) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Bleeding Disorders Treatment (Other Drug Classes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Bleeding Disorders Treatment (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Bleeding Disorders Treatment (Hospital Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Bleeding Disorders Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Bleeding Disorders Treatment (Retail Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Bleeding Disorders Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Bleeding Disorders Treatment (Online Stores) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Bleeding Disorders Treatment (Online Stores) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Bleeding Disorders Treatment (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Bleeding Disorders Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Global: Bleeding Disorders Treatment (Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Global: Bleeding Disorders Treatment (Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Global: Bleeding Disorders Treatment (Academic and Research Institutes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Global: Bleeding Disorders Treatment (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: North America: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: North America: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: United States: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: United States: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Canada: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Canada: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Asia-Pacific: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Asia-Pacific: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: China: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: China: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Japan: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Japan: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: India: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: India: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: South Korea: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: South Korea: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Australia: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Australia: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Indonesia: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Indonesia: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Others: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Others: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Europe: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Europe: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Germany: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Germany: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: France: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: France: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: United Kingdom: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: United Kingdom: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Italy: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Italy: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Spain: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Spain: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Russia: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Russia: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Others: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Others: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Latin America: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Latin America: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Brazil: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Brazil: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Mexico: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Mexico: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Others: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 86: Others: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 87: Middle East and Africa: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 88: Middle East and Africa: Bleeding Disorders Treatment Market: Breakup by Country (in %), 2021
Figure 89: Middle East and Africa: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 90: Global: Bleeding Disorders Treatment Industry: SWOT Analysis
Figure 91: Global: Bleeding Disorders Treatment Industry: Value Chain Analysis
Figure 92: Global: Bleeding Disorders Treatment Industry: Porter's Five Forces Analysis
• 日本語訳：出血性疾患治療の世界市場：動向・シェア・規模・予測
• レポートコード：MRC-IM30337 ▷ お問い合わせ（見積依頼・ご注文・質問）